|
PM20D2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.661800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.986980E-01 |
| Normal-vs-Stage2 |
6.381200E-01 |
| Normal-vs-Stage3 |
4.850800E-01 |
| Normal-vs-Stage4 |
2.393000E-01 |
| Stage1-vs-Stage2 |
3.713400E-01 |
| Stage1-vs-Stage3 |
2.569000E-01 |
| Stage1-vs-Stage4 |
5.197700E-02 |
| Stage2-vs-Stage3 |
8.807400E-01 |
| Stage2-vs-Stage4 |
5.697600E-01 |
| Stage3-vs-Stage4 |
6.841600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.336600E-01 |
| Normal-vs-AfricanAmerican |
7.919000E-01 |
| Normal-vs-Asian |
2.202300E-02 |
| Caucasian-vs-AfricanAmerican |
7.502200E-01 |
| Caucasian-vs-Asian |
3.116200E-01 |
| AfricanAmerican-vs-Asian |
2.804600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.178800E-01 |
| Normal-vs-Female |
4.606800E-01 |
| Male-vs-Female |
3.331200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.367000E-01 |
| Normal-vs-Extreme_Weight |
2.819500E-02 |
| Normal-vs-Obese |
1.166410E-01 |
| Normal-vs-Extreme_Obese |
7.567000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.304600E-01 |
| Normal_Weight-vs-Obese |
3.178300E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.586200E-01 |
| Extreme_Weight-vs-Obese |
6.118900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.344800E-01 |
| Obese-vs-Extreme_Obese |
3.854200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.050170E-01 |
| Normal-vs-Age(41-60Yrs) |
1.108000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.703700E-02 |
| Normal-vs-Age(81-100Yrs) |
4.340300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.452800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.527800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.460500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.559200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.776500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.812400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.939400E-01 |
| Normal-VS-Type2 PRCC |
3.638900E-03 |
| Normal-VS-KIRP CIMP |
1.156370E-02 |
| Normal-VS-Unclassified PRCC |
9.021000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.796900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.566130E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.432200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.883000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.492000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.404030E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.151600E-02 |
| Normal-vs-N1 |
2.026300E-02 |
| Normal-vs-N2 |
1.118710E-03 |
| N0-vs-N1 |
2.778800E-03 |
| N0-vs-N2 |
3.361800E-01 |
| N1-vs-N2 |
5.194100E-02 |
|
|
